378 related articles for article (PubMed ID: 7774637)
1. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
[TBL] [Abstract][Full Text] [Related]
2. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
Lund FE; Yu N; Kim KM; Reth M; Howard MC
J Immunol; 1996 Aug; 157(4):1455-67. PubMed ID: 8759726
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells.
Yamashita Y; Miyake K; Kikuchi Y; Takatsu K; Noda S; Kosugi A; Kimoto M
Immunology; 1995 Jun; 85(2):248-55. PubMed ID: 7642213
[TBL] [Abstract][Full Text] [Related]
4. Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice.
Yellen AJ; Glenn W; Sukhatme VP; Cao XM; Monroe JG
J Immunol; 1991 Mar; 146(5):1446-54. PubMed ID: 1847161
[TBL] [Abstract][Full Text] [Related]
5. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
6. A polyclonal model for B cell tolerance. I. Fc-dependent and Fc-independent induction of nonresponsiveness by pretreatment of normal splenic B cells with anti-Ig.
Warner GL; Scott DW
J Immunol; 1991 Apr; 146(7):2185-91. PubMed ID: 1672346
[TBL] [Abstract][Full Text] [Related]
7. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
Kitanaka A; Ito C; Coustan-Smith E; Campana D
J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454
[TBL] [Abstract][Full Text] [Related]
8. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy.
Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ
J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209
[TBL] [Abstract][Full Text] [Related]
9. CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism.
Lund FE; Muller-Steffner H; Romero-Ramirez H; Moreno-García ME; Partida-Sánchez S; Makris M; Oppenheimer NJ; Santos-Argumedo L; Schuber F
Int Immunol; 2006 Jul; 18(7):1029-42. PubMed ID: 16720618
[TBL] [Abstract][Full Text] [Related]
10. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
[TBL] [Abstract][Full Text] [Related]
11. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance.
Gause A; Yoshida N; Kappen C; Rajewsky K
Eur J Immunol; 1987 Jul; 17(7):981-90. PubMed ID: 3497044
[TBL] [Abstract][Full Text] [Related]
12. CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain.
Kitanaka A; Suzuki T; Ito C; Nishigaki H; Coustan-Smith E; Tanaka T; Kubota Y; Campana D
J Immunol; 1999 Feb; 162(4):1952-8. PubMed ID: 9973464
[TBL] [Abstract][Full Text] [Related]
13. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.
Donís-Hernández FR; Parkhouse RM; Santos-Argumedo L
Eur J Immunol; 2001 Apr; 31(4):1261-7. PubMed ID: 11298353
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
Scott DW; O'Garra A; Warren D; Klaus GG
J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
[TBL] [Abstract][Full Text] [Related]
15. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
Phillips NE; Gravel KA; Tumas K; Parker DC
J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
Baluyut AR; Subbarao B
J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
18. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
Golay J; Erba E; Bernasconi S; Peri G; Introna M
J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
Rigley KP; Callard RE
Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
[TBL] [Abstract][Full Text] [Related]
20. Sarcoplasmic reticulum-associated and protein kinase C-regulated ADP-ribosyl cyclase in cardiac muscle.
Mészáros LG; Wrenn RW; Váradi G
Biochem Biophys Res Commun; 1997 May; 234(1):252-6. PubMed ID: 9168998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
